Dr. Tsao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 Staniford St
Suite 200
Boston, MA 02114Phone+1 617-726-2914Fax+1 617-724-2135
Education & Training
Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1994 - 1997
Brigham and Women's HospitalInternship, Internal Medicine, 1993 - 1994
Columbia University Vagelos College of Physicians and SurgeonsClass of 1993
Certifications & Licensure
MA State Medical License 1997 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Boston Magazine Castle Connolly, 2010-2013
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
- Join now to see all
Publications & Presentations
PubMed
- Recent progress in cancer vaccines and nanovaccines.Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, Hensin Tsao
Biomaterials. 2025-03-01 - Analysis of variants induced by combined ex vivo irradiation and in vivo tumorigenesis suggests a role for the ZNF831 p.R1393Q mutation in cutaneous melanoma development.Dmitrii Usoltsev, Ching-Ni Njauw, Zhenyu Ji, Raj Kumar, Alexey Sergushichev
The Journal of Investigative Dermatology. 2024-12-13 - ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence.Emily Everdell, Jenna Borok, Alana Deutsch, Ziyou Ren, Justine V Cohen
Journal of the American Academy of Dermatology. 2024-12-01
Other
- Consensus, Controversy, and Conversations About Gene Expression Profiling in MelanomaHensin Tsao, MD, JAMA Dermatology
https://www.doximity.com/articles/6e8c522a-ea07-497d-b457-77193fc28b29
UpToDate, Wolters Kluwer Health - 2012-03-23
Authored Content
- Consensus, Controversy, and Conversations About Gene Expression Profiling in MelanomaJuly 2020
Press Mentions
Novel Therapy Shows Promise for Treating Skin-Predominant DermatomyositisMarch 21st, 2023- Novel Therapy Shows Promise for Treating Skin-Predominant DermatomyositisMarch 21st, 2023
- Melanoma Research Alliance Announces $8.1 Million in Research AwardsApril 27th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
